Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.
about
Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsQuantifying progression and regression of thrombotic risk in experimental atherosclerosisRecent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.Perfluorocarbon nanoparticles for physiological and molecular imaging and therapyPerspectives and opportunities for nanomedicine in the management of atherosclerosis.Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors.Intracellular pH measurements using perfluorocarbon nanoemulsionsThrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces.Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury.Nanomedical Theranostics in Cardiovascular Disease.Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental AtherosclerosisThrombosis: Novel nanomedical concepts of diagnosis and treatmentBLOOD TRIGGERED RAPID RELEASE POROUS NANOCAPSULES.Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions.Vascular Inflammation: A Novel Access Route for NanomedicineThrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis.Advances in nanotechnology for the management of coronary artery disease.Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.Theranostic nanoparticles for cancer and cardiovascular applications.Engineered nanoparticles: thrombotic events in cancer.Modifications of natural peptides for nanoparticle and drug design.The Future of Nanoparticle-Directed Venous Therapy.The melding of nanomedicine in thrombosis imaging and treatment: a review.Nanomedicine applied to cardiovascular diseases: latest developments.Nanomedicine in coronary artery disease.Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.An unmet clinical need: The history of thrombus imaging.Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy.Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology.Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor ModelAnti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice
P2860
Q27027613-38A69034-C57D-47BF-80EE-ABA33EFC8698Q27318779-56EB19BF-EBAF-4E0C-B634-4C74B2147816Q30385272-3AE3E62F-9516-4FC2-B9E1-5D9A36DCFB89Q30426880-D9D37CA9-B6F5-4FBC-A1C0-3A8E16F6D2BAQ30455490-7D88F25F-F08D-486C-9DDB-8CE436FBDD9BQ30586518-DF624A3D-B55E-4E0E-B573-A978580B443CQ34399286-03711146-F3E9-45A8-8D7B-478C8712BE82Q34545939-1E2B9202-DAFB-4BBE-9B10-B0CA0283B4DBQ35274033-3FD81DB5-3091-4D50-AC3D-5213DC1A95B7Q35681183-5D5273C7-31A9-4773-8F27-885CE804597AQ35894640-44961EEB-B10B-4F02-8B88-812CD4F91899Q35996696-3DFA9502-206A-4C91-BDCD-E637777312BFQ36768912-D25B8018-DE69-47A5-97A4-C6304E47B12BQ37064676-F312F597-B922-44F1-ACC5-AB145B7B54D8Q37397963-528004BC-6E58-4A08-86B5-EBFDFBE34FC6Q37624589-73688DDE-FE12-447D-A1AE-F1A493B83799Q38067933-6A053CF5-5143-4289-85CD-BBFCDC9FEB8CQ38112504-2B351988-D45E-46FD-9186-C8905EAB0A41Q38193333-288F5B25-51A3-43C8-8B2C-5CCCD3C6161EQ38262939-6E7E8280-01B1-426E-BD6B-27DE8870FAADQ38369494-3FA54DB8-52F0-4E89-9F5E-101AB5E54731Q38749932-7C655318-DAD5-4108-B737-B6AF306D6087Q38776819-6D0AB4A8-CFCB-435E-AAC0-55C6AD8A93D8Q39136197-4700F071-FEB3-4C14-B0B2-B3177757DE42Q39276023-09D6227B-C843-49D0-AE93-17BD21205292Q42877162-BA82FE47-9484-42C6-B996-401A45ACABC8Q47177380-797149D7-DD97-48DA-9A92-3B0848DB06F7Q47338726-52D1CAAE-D67A-467D-96C1-F6D13138FECCQ47642528-162068D2-BB8D-4D9D-970B-BECA33E9563DQ48089546-69E91547-CBF2-408F-A86F-1A27C9CA19C9Q58726802-FF6667B4-ECF5-4926-BFFE-61608E60C6E3Q58761484-1570E51B-559A-4261-B10A-048F8FAC2898
P2860
Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@en
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@nl
type
label
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@en
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@nl
prefLabel
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@en
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@nl
P2093
P2860
P921
P1476
Thrombin-inhibiting perfluoroc ...... e imaging of acute thrombosis.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2011.04339.X
P577
2011-07-01T00:00:00Z